Press Release – Page 3 – NCAL Research Spotlight

Kaiser Permanente data key to nation’s COVID-19 vaccine surveillance strategy

January 6, 2021
COVID19, Infectious disease, Informatics, Press Release, Uncategorized, Vaccine research, Vaccines
0 Comments

Kaiser Permanente’s Vaccine Study Center is leading a key part of the national safety surveillance effort for the COVID-19 vaccines, tracking patient data for serious side effects.

Pediatrician screening of young people with substance use, mood problems can have long-term results

December 28, 2020
Adolescent Health, Alcohol and drug, Behavioral health, Mental health, Press Release, Uncategorized
0 Comments

Adolescents who had access to a brief intervention and referral to treatment for substance use or mood problems at a pediatric clinic were less likely to have a related diagnosis 3 years later, new Kaiser Permanente research finds.

Unique genetic factors and ancestry, along with lifestyle, influence skin cancer risk

December 14, 2020
Cancer, Genetics, Press Release, Skin diseases
0 Comments

People can look to the Northern European side of their genetic heritage for increased risk of nonmelanoma skin cancer, according to the first large analysis of genetic risk factors for cutaneous squamous cell carcinoma in diverse populations with European ancestry from Kaiser Permanente researchers.

Real-time in-hospital alerts associated with lower patient mortality

November 11, 2020
Critical care, Delivery Science, Hospital systems, Press Release, Uncategorized
0 Comments

A sophisticated system that analyzes electronic data about hospital patients, identifies those at risk of deteriorating, and issues an alert to a centralized team of specially trained nurses resulted in a lower mortality rate, Kaiser Permanente researchers reported in the New England Journal of Medicine.

Active tuberculosis linked to higher long-term risk of death

People who recovered from active tuberculosis had a higher long-term risk of death from any cause than similar patients who never had active tuberculosis shows a new Kaiser Permanente study.

Teens, parents, physicians support screening young people for gender identity, study suggests

September 14, 2020
Adolescent Health, Podcast, Press Release, Puberty
0 Comments

Teenagers who question their gender identity may not feel comfortable bringing up the issue with their doctors. New research suggests that adding gender identity questions to a pre-visit screening could make those conversations easier.

Study identifies geographic clusters of pregnant women who missed flu shots

September 8, 2020
Infectious disease, Maternal/infant health, Perinatal health, Press Release, Vaccine research, Vaccines, Women’s health
0 Comments

A Kaiser Permanente analysis of women who did not get flu shots during their pregnancies found the women clustered in geographic “hot spots.” These women tended to have fewer prenatal medical visits and live in low-income neighborhoods.

Kaiser Permanente joins late-stage COVID-19 vaccine study

August 12, 2020
Infectious disease, Press Release, Vaccine research, Vaccines
0 Comments

The Division of Research has joined a phase 3 clinical trial testing a Pfizer/BioNTech vaccine against the COVID-19 virus. Kaiser Permanente Southern California and Northwest join them in this global effort.

Early colorectal cancer screening benefits African Americans

July 20, 2020
Cancer, Delivery Science, Disparities, Gastroenterology, Health disparities, Press Release, Prevention
0 Comments

Kaiser Permanente researchers showed starting annual colorectal cancer screening at age 45 in African Americans can find colorectal cancers at a rate similar to that seen when screening starts after age 50 — the age most guidelines currently recommend.

Kaiser Permanente researchers develop new prostate cancer risk calculator

July 13, 2020
Cancer, Comparative Effectiveness Research, Delivery Science, Men’s health, Press Release, Prevention
0 Comments

A new prostate cancer risk calculator developed by Kaiser Permanente Northern California researchers may help men going through prostate cancer screening decide whether to have a prostate biopsy.